Search

Displaying results 5891 - 5900 of 8171 in total
  1. Drug

    Mepramidil

    go.drugbank.com/drugs/DB20025
    Experimental

    Mepramidil has a monoisotopic molecular weight of 463.24 Da.

  2. Drug

    Mapinastine

    go.drugbank.com/drugs/DB20076
    Experimental

    Mapinastine has a monoisotopic molecular weight of 410.28 Da.

  3. Drug

    Palinavir

    go.drugbank.com/drugs/DB20083
    Experimental

    Palinavir has a monoisotopic molecular weight of 708.4 Da.

  4. Drug

    Zanoterone

    go.drugbank.com/drugs/DB21384
    Experimental

    Zanoterone has a monoisotopic molecular weight of 416.21 Da.

  5. Drug

    Bamirastine

    go.drugbank.com/drugs/DB21186
    Experimental

    Bamirastine has a monoisotopic molecular weight of 527.29 Da.

  6. Drug

    Barmastine

    go.drugbank.com/drugs/DB21253
    Experimental

    Barmastine has a monoisotopic molecular weight of 483.24 Da.

  7. Drug

    Pemlimogene merolisbac

    go.drugbank.com/drugs/DB16286
    Investigational

    Pemlimogene merolisbac is under investigation in clinical trial NCT03371381 (An Efficacy and Safety Study of JNJ-64041757, a Live Attenuated Listeria Monocytogenes Immunotherapy, in Combination With Nivolumab

  8. Drug

    SNS01-T

    go.drugbank.com/drugs/DB17302
    Investigational

    It is composed of three components: a B cell-specific plasmid expressing eIF5AK50R; an siRNA that targets the native eIF5A that promotes growth/anti-apoptosis of cancer cells; and polyethylenimine.

  9. Drug

    HGTV-43

    go.drugbank.com/drugs/DB05807
    Experimental

    HGTV43 is an anti-sense treatment designed to produce T cells that are genetically resistant to HIV infection.

  10. Drug

    Lutetium (177Lu) NeoB

    go.drugbank.com/drugs/DB30389
    Investigational

    Lutetium (177Lu) NeoB is under investigation in clinical trial NCT06379217 (NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine

    Synonyms: Lu-NeoB, [177Lu]Lu-NeoB